SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-036148
Filing Date
2024-03-19
Accepted
2024-03-19 16:15:32
Documents
16
Period of Report
2024-03-19
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249239d1_8k.htm   iXBRL 8-K 28340
2 EXHIBIT 99.1 tm249239d1_ex99-1.htm EX-99.1 73860
7 GRAPHIC image_003.jpg GRAPHIC 33249
  Complete submission text file 0001104659-24-036148.txt   376733

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycc-20240319.xsd EX-101.SCH 3260
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20240319_def.xml EX-101.DEF 26928
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20240319_lab.xml EX-101.LAB 36551
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20240319_pre.xml EX-101.PRE 25552
19 EXTRACTED XBRL INSTANCE DOCUMENT tm249239d1_8k_htm.xml XML 5355
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 24763418
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)